Showing results (61-70 of 160) with videos related to
Sort By:
Pageof 16
The Journal of Antimicrobial Chemotherapy|August 9, 2012
Development and validation of a new method to simultaneously quantify triazoles in plasma spotted on dry sample spot devices and analysed by HPLC-MSLorena Baietto, Antonio D'Avolio, Cristina Marra, et al.Biomedicines|August 26, 2023
Hormone Receptors and Epithelial Ovarian Cancer: Recent Advances in Biology and Treatment OptionsFulvio Borella, Stefano Fucina, Luca Mangherini, et al.International Journal of Antimicrobial Agents|June 3, 2026
Amoxicillin bone penetration in patients with medication-related osteonecrosis of the jaw: a preliminary studyJessica Cusato, Alessandra Manca, Virginia Moscone, et al.Pharmacogenetics and Genomics|September 5, 2018
Role of CYP1A1, ABCG2, CYP24A1 and VDR gene polymorphisms on the evaluation of cardiac iron overload in thalassaemia patientsSarah Allegra, Jessica Cusato, Silvia De Francia, et al.The Journal of Antimicrobial Chemotherapy|September 22, 2018
High efavirenz serum concentrations in TB/HIV-coinfected Ugandan adults with a CYP2B6 516 TT genotype on anti-TB treatmentAmrei von Braun, Barbara Castelnuovo, Bruno Ledergerber, et al.The Pharmacogenomics Journal|January 18, 2019
The effect of vitamin D pathway genes and deferasirox pharmacogenetics on liver iron in thalassaemia major patientsSarah Allegra, Jessica Cusato, Silvia De Francia, et al.Infection|November 18, 2016
Treatment with daclatasvir and sofosbuvir for 24 weeks without ribavirin in cirrhotic patients who failed first-generation protease inhibitorsLucio Boglione, Simone Mornese Pinna, Chiara Simona Cardellino, et al.Current Issues in Molecular Biology|September 29, 2025
Tumor Immune Microenvironment and Checkpoint Inhibition in Clear Cell Ovarian Carcinoma: Bridging Tumor Biology and Clinical Application in ImmunotherapyFulvio Borella, Giulia Capella, Stefano Cosma, et al.Journal of Pharmaceutical and Biomedical Analysis|November 1, 2011
HPLC-MS method for the simultaneous quantification of the antileukemia drugs imatinib, dasatinib and nilotinib in human peripheral blood mononuclear cell (PBMC)Antonio D'Avolio, Marco Simiele, Silvia De Francia, et al.Liver International : Official Journal of the International Association for the Study of the Liver|January 15, 2013
Kinetics and prediction of HBsAg loss during therapy with analogues in patients affected by chronic hepatitis B HBeAg negative and genotype DLucio Boglione, Antonio D'Avolio, Giuseppe Cariti, et al.Pageof 16